Business Wire

Amazon Studios Orders Fourth Season of the Award-Winning Comedy The Marvelous Mrs. Maisel

13.12.2019 02:10:00 EET | Business Wire | Press release

Share

(NASDAQ:AMZN) – Amazon Studios announced today that it has ordered a fourth season of the Emmy and Golden Globe-Award winning comedy The Marvelous Mrs. Maisel. The third season premiered Friday, Dec. 6 on Amazon Prime Video in more than 200 countries and territories worldwide. The Marvelous Mrs. Maisel received two Golden Globe nominations this week, for Best Television Series, Musical or Comedy, and for star Rachel Brosnahan for Best Performance by an Actress in a Series, Musical or Comedy.

“We were thrilled to hear that for the fourth time, we do not have to pack up and vacate the premises,” said Creator and Executive Producer Amy Sherman-Palladino and Executive Producer Daniel Palladino. “We’d like to thank Amazon for all their faith and support, their partnership and enthusiasm, and for letting us hang with our favorite people, the cast and crew of Maisel, for a little while longer.”

The Marvelous Mrs. Maisel has been a worldwide phenomenon, and Season 3 has been no exception, with the series’ most watched opening weekend ever. We’re so happy that our Prime Video customers will get to see Midge’s story continue in Season 4,” said Jennifer Salke, Head of Amazon Studios. “Amy and Dan have created such funny, charming, relatable characters, all with their inimitable wit and eye for detail, and our customers around the world will be delighted to have another season in the world of The Marvelous Mrs. Maisel.”

In Season Three of The Marvelous Mrs. Maisel, Midge and Susie discover that life on tour with Shy is glamorous but humbling, and they learn a lesson about show business they’ll never forget. Joel struggles to support Midge while pursuing his own dreams, Abe embraces a new mission and Rose learns she has talents of her own.

The Marvelous Mrs. Maisel is the winner of sixteen Emmy Awards including Outstanding Comedy series, three Golden Globes including Best TV Series—Comedy, five Critics’ Choice Awards including Best Comedy Series, two PGA Awards, a WGA Award, and a Peabody Award.

The Marvelous Mrs. Maisel stars Emmy and Golden Globe winner Rachel Brosnahan, Golden Globe winner and four-time Emmy winner Tony Shalhoub, two-time Emmy winner Alex Borstein, Emmy nominee Marin Hinkle, Michael Zegen, Kevin Pollak, Caroline Aaron and Emmy winner Jane Lynch.

Prime members can stream The Marvelous Mrs. Maisel at www.amazon.com/Maisel Members can also download the series to mobile devices for offline viewing at no additional cost to their membership. The series is a global release and available on PrimeVideo.com for Prime Video members in more than 200 countries and territories. Watch where and when you want with the Prime Video app on your smart TV, mobile device, Fire TV, Fire tablet, Apple TV, Chromecast, game consoles, Comcast X1 or from the web. For a complete list of compatible devices, visit amazon.com/howtostream. Customers who are not already Prime members can sign up for a free trial at www.amazon.com/prime.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 20269.2.2026 14:00:00 EET | Press release

Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206015371/en/ “You can now potentially study intracellular target engagement for any protein in live cells,” says M

Eurofins Viracor BioPharma Expands Bioanalytical Capabilities9.2.2026 14:00:00 EET | Press release

Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow. This strategic advancement follows the successful relocation and integration of Eurofins Pharma Bioanalytics Services from St. Charles, Missouri, into Eurofins Viracor BioPharma’s purpose‑built, eleven‑acre facility in Lenexa, Kansas. The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories’ strengths, Eurofins V

HKTDC to Host World’s Largest One-Stop Jewellery Marketplace9.2.2026 12:37:00 EET | Press release

Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one‑stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld‑Expo, featuring a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre, showcasing finished jewellery pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260207153040/en/ Hong Kong International Jewellery Show and Hong Kong International Diamond, Gem & Pearl Show Jenny Koo, Deputy Executive Director of the HKTDC, said: “This year’s twin jewellery shows bring together some 4,000 exhibitors from over 40 countries and regions, with nearly 70% coming from outside Hong Kong. The HKTDC presents the world’s largest one-s

FlexTrade Integrates CME Group’s FX Spot+ and EBS Market Offerings for Enhanced FX Trading9.2.2026 12:30:00 EET | Press release

FlexTrade Systems(@FlexTrade), a global leader in multi-asset execution and order management systems, today announced an integration with CME Group’s EBS Market central limit order book (CLOB) and its FX Spot+ platform.The move is designed to diversify and deepen the sources of actionable liquidity available to FlexTrade’s FlexFX users through an integration into CME Group's substantial liquidity pools for spots via FX Spot+. Providing firm, anonymous liquidity and no last-look pricing, EBS Market is a venue for both large market participants in search of FX liquidity in an all-to-all CLOB, and for market-making banks hedging FX risk. FX Spot+ further enhances spot liquidity with Futures liquidity from CME Group. This partnership is integral in helping firms further expand FX liquidity and take advantage of global opportunity. Mutual clients of FlexTrade and CME Group can integrate FX Spot+ and EBS Market liquidity into their existing FlexFX workflows, accelerating time to market and r

Clearwater Analytics Debuts Transparent Risk Platform for Power and Gas Markets at E-world 20269.2.2026 10:00:00 EET | Press release

At E-world Energy & Water 2026, Clearwater Analytics (NYSE: CWAN) will debut CWAN Power and Gas, new risk management capabilities within Beacon by CWAN designed to end the industry’s reliance on black-box systems. With transparent methodologies and source-code visibility, the platform lets trading teams validate and customize calculations for complex power and gas instruments in real time. Visit Booth #5A118 in Hall 5 for live demonstrations. Renewables growth, liquefied natural gas flows, and shifting macroeconomic conditions are reshaping power markets and increasing both volatility and opportunity. Yet many trading firms remain constrained by legacy risk platforms that limit model visibility, customization, and speed-to-market. CWAN Power and Gas removes those constraints by making every calculation transparent, configurable, and auditable in real time—supporting complex instruments such as structured power derivatives and evolving trading strategies. “The energy transition is creat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye